CoChat

Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

The present study reports the results of an open-label trial on the use of the combination of olanzapine (an atypical antipsychotic) serotonin reuptake inhibitors (SRIs) in 26 resistant outpatients affected by resistant obsessive-compulsive disorder (OCD). All patients had been suffering from OCD, according to DSM IV criteria, for at least 2 years and had different comorbid disorders; they had been treated with an SRI at adequate dosages for at least 6 months, or had tried different augmentation strategies with no or poor response. As a result, olanzapine was added and continued for 1 year. After 12 weeks of this regimen, most of the patients (17) had shown a reduction in OC symptoms, as assessed by a decrease in the Yale-Brown Obsessive Compulsive Scale total score, which continued throughout subsequent months. Only mild side-effects were recorded and no patient halted the treatment. The addition of olanzapine would appear to be a useful short- and long-term strategy for augmenting SRI effectiveness in resistant OCD patients, especially in those presenting comorbidity with bipolar disorders.

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881105053299

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 20 references

Research works printed but not linked: 6

  1. Amador X F, 1994, Am J Psychiatry, 150, 873
  2. 10.3109/9780203212899 · doi:10.3109/9780203212899
  3. First M B, 1997, Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition
  4. McDougle C J, 1997, J Clin Psychiatry, 58, 11
  5. McDougle C J, 1994, J Clin Psychiatry, 55, 24
  6. Stein D J, 1992, J Clin Psychiatry, 53, 123

Cited by

See all 56

Metadata

Authors
Marazziti, D., Pfanner, C., Dell’osso, B., Ciapparelli, A., Presta, S., Corretti, G., Di Nasso, E., Mungai, F., & Dell’osso, L.
Affiliations
  • University of Pisa (IT)
  • Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa, Pisa, Italy.
Venue
Journal of Psychopharmacology
Published
2005-07
Volume
19
Issue
4
Pages
392-394
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2089496191
Cited by
56
References
20
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2020: 1 · 2019: 4 · 2018: 2 · 2016: 3 · 2015: 5 · 2014: 2 · 2013: 1 · 2012: 5
FWCI
5.79
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
Keywords
olanzapine, treatment-resistant OCD, augmentation strategies, serotonin reuptake inhibitors, atypical antipsychotics, bipolar disorder comorbidity, Yale-Brown Obsessive Compulsive Scale, adverse effects
MeSH terms
Olanzapine, Adult, Benzodiazepines, Bipolar Disorder, Drug Resistance, Female, Humans, Italy, Long-Term Care, Male, Obsessive-Compulsive Disorder, Psychiatric Status Rating Scales, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study. https://app.cochat.ai/papers/10.1177/0269881105053299
The paper
Marazziti, D., Pfanner, C., Dell’osso, B., Ciapparelli, A., Presta, S., Corretti, G., Di Nasso, E., Mungai, F., & Dell’osso, L. (2005). Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study. Journal of Psychopharmacology. https://doi.org/10.1177/0269881105053299

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.